Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

ESMO Congress 2022

09 - 13 Sep 2022

Paris, France

ESMO-Congress-2022-1000x1000

Resources are available according to the presenters' agreement to release them. ESMO thanks the authors for their generosity.

Abstracts and ePosters are open access.
Slides and webcasts are reserved to registered Delegates (6 months). ESMO Members will get access on 13 Dec 2022 for 5 years.

Understanding the disease to provide better CARE for #cancer patients

Practice changing data and high quality education in more than 20 tracks covering all tumour types, therapeutic innovations, translational research, patient advocacy, public policy, and more...


Congress coverage: Expert video reports  |  Highlight videos  |  News articles 

Quick access to special sessions

Open access - Clinical Practice Guidelines session 1 (eBC, CUP, Biliary tract)

Open access - Clinical Practice Guidelines session 2 (Bladder, CNS Lymphoma, mNSCLC)

ESMO Colloquia

Satellite webcasts from our Industry partners

Hide
Filter by:

There are 2867 resources available

Presentation by Expert

Presenter: Nick Turner

Session: How can we use ctDNA for early detection of cancer?

Resources:

Slides

Webcast

Presentation of case/condition 

Presenter: Carlos Barrios

Session: Oligometastatic disease and oligoprogression in breast cancer

Resources:

Slides

Webcast

Presentation of case/condition 

Presenter: Omid Hamid

Session: Molecular tumor boards: Challenges in identifying personalised treatments for melanoma patients

Resources:

Slides

Webcast

Introduction by the chair

Presenter: Elizabeth Smyth

Session: PD-L1 is a good predictive biomarker for anti-PD-1 therapy in oesophagogastric cancer

Resources:

Slides

Webcast

The basic scientist’s perspective

Presenter: Richard Marais

Session: Molecular tumor boards: Challenges in identifying personalised treatments for melanoma patients

Resources:

Slides

Webcast

Polling 1 (led by chair)

Presenter: All Speakers

Session: PD-L1 is a good predictive biomarker for anti-PD-1 therapy in oesophagogastric cancer

Resources:

Slides

Webcast

Systemic therapeutic options

Presenter: Javier Cortés

Session: Oligometastatic disease and oligoprogression in breast cancer

Resources:

Slides

Webcast

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.